Form 8-K - Current report:
SEC Accession No. 0001628908-23-000183
Filing Date
2023-12-06
Accepted
2023-12-06 06:09:44
Documents
14
Period of Report
2023-12-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 12.05.2023 8-K 2029 NOTE PRICING evh-20231205.htm   iXBRL 8-K 29615
2 EX-99.1 2029 NOTE PRICING exhibit991pressrelease1252.htm EX-99.1 14256
6 evhnewlogoa.jpg GRAPHIC 30853
  Complete submission text file 0001628908-23-000183.txt   222859

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20231205.xsd EX-101.SCH 1916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20231205_lab.xml EX-101.LAB 25852
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20231205_pre.xml EX-101.PRE 13592
8 EXTRACTED XBRL INSTANCE DOCUMENT evh-20231205_htm.xml XML 2940
Mailing Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203
Business Address 800 NORTH GLEBE RD, SUITE 500 ARLINGTON VA 22203 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 231468362
SIC: 8741 Services-Management Services